Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
- PMID: 19173306
- DOI: 10.1002/prot.22353
Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
Abstract
The epidermal growth factor receptor (EGFR) has been the focus of intensive studies because of its importance in cancer research. Thus, a broader understanding of the molecular mechanism of activation of the EGFR kinase will have profound significance for the development of novel therapeutics. Numerous crystal structures of EGFR kinase, including the structure of the activating-kinase dimer, have provided snapshots of the specific pathway. Herein, we performed unrestrained-, as well as targeted-molecular dynamics simulations based on these data, to gain further insight into the conformational changes responsible for activation. Comparison of the monomer- versus activating-EGFR-dimer simulations indicates that the dimerization is stabilizing structural elements associated with the activated state and predicts new salt-bridge interactions involving activation-loop residues that may also be associated with that state. Targeted molecular dynamics simulations of the inactive-to-active EGFR transition, as well as the reverse pathway, confirm the formation of conserved structural features of functional importance for the activity or stabilization of either conformation. Interestingly, simulations of the L834R mutant, which is associated with cancer, suggest that the structural basis of the activation induced by that mutation might be the ability of the mutated R834 residue to consecutively form salt bridges with neighboring acidic residues and cause destabilization of a hydrophobic cluster in the inactive state.
2008 Wiley-Liss, Inc.
Similar articles
-
Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.Proteins. 2011 Jan;79(1):99-114. doi: 10.1002/prot.22862. Epub 2010 Oct 11. Proteins. 2011. PMID: 20938978
-
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.Cell. 2006 Jun 16;125(6):1137-49. doi: 10.1016/j.cell.2006.05.013. Cell. 2006. PMID: 16777603
-
Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations within the epidermal growth factor receptor.J Comput Chem. 2011 Oct;32(13):2843-52. doi: 10.1002/jcc.21866. Epub 2011 Jun 30. J Comput Chem. 2011. PMID: 21717480
-
Mechanisms for oncogenic activation of the epidermal growth factor receptor.Cell Signal. 2007 Oct;19(10):2013-23. doi: 10.1016/j.cellsig.2007.06.023. Epub 2007 Jul 4. Cell Signal. 2007. PMID: 17681753 Review.
-
Active and inactive conformations of the epidermal growth factor receptor.Biochem Soc Trans. 2004 Nov;32(Pt 5):742-5. doi: 10.1042/BST0320742. Biochem Soc Trans. 2004. PMID: 15494003 Review.
Cited by
-
Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases.PLoS Comput Biol. 2011 Oct;7(10):e1002179. doi: 10.1371/journal.pcbi.1002179. Epub 2011 Oct 6. PLoS Comput Biol. 2011. PMID: 21998569 Free PMC article.
-
Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.PLoS One. 2014 Nov 26;9(11):e113488. doi: 10.1371/journal.pone.0113488. eCollection 2014. PLoS One. 2014. PMID: 25427151 Free PMC article.
-
Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.PLoS Comput Biol. 2014 Jan;10(1):e1003435. doi: 10.1371/journal.pcbi.1003435. Epub 2014 Jan 16. PLoS Comput Biol. 2014. PMID: 24453959 Free PMC article.
-
Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.Sci Signal. 2017 Sep 5;10(495):eaam9931. doi: 10.1126/scisignal.aam9931. Sci Signal. 2017. PMID: 28874603 Free PMC article.
-
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators.Cancers (Basel). 2023 Oct 16;15(20):5009. doi: 10.3390/cancers15205009. Cancers (Basel). 2023. PMID: 37894376 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous